二甲双胍在老年糖尿病患者中应用的现状调查
Investigation on the Application of Metformin in Elderly Diabetic Patients
DOI: 10.12677/ACM.2020.106154, PDF,   
作者: 代泳宇*:青岛大学,山东 青岛;陈 瞳, 张利方, 张雪娟, 张杰涛#:青岛大学附属医院全科医学科,山东 青岛
关键词: 二甲双胍肾功能老年糖尿病合理用药现状调查Metformin Renal Function Elderly Patients with Diabetes Mellitus The Rational Use of Drugs Investigation
摘要: 目的:调查某综合医院老年2型糖尿病(Type 2 Diabetes Mellitus, T2DM)患者,在不同肾功能水平下二甲双胍实际应用情况,指导合理用药。方法:利用医院医疗信息管理系统(HIS系统),调取该院2012年4月至2019年6月住院的老年T2DM患者病例,提取该患者年龄、性别、住院科室、血清肌酐(Serum creatinine, Scr)、糖化血红蛋白(Hemoglobin A1c, HbA1c)及二甲双胍的应用情况,计算患者平均肾小球滤过率(Epidermal growth factor receptor, eGFR),结合相关指南判断患者的二甲双胍应用情况。结果:1) 共收集资料齐全的老年T2DM患者16550例,1117例存在二甲双胍使用不合理,不合理用药率9.59%,其中347例(2.10%)未及时停药,770例(4.65%)未及时调整剂量;2) 1117例不合理用药患者中,男性384例(34.38%),女性733例(65.62%),人均年龄(75.92 ± 6.62)岁。其中Scr位于正常值范围内,但eGFR小于45 ml/(min∙1.73 m2)共198例,占17.73%。其中Scr位于正常值范围内,但eGFR 45~60 ml/(min∙1.73 m2)共762例,占68.22%。3) 用药科室不合理分布中,心血管内科居首位,占26.95%,其次为内分泌内科、综合内科、神经内科、保健科、急诊与重症、肾病科,累计构成比在91.79%。结论:综合医院老年糖尿病患者中存在二甲双胍用药不合理现象,用药时应避免单纯根据Scr来判断肾功能状况,应采取多种措施共同促进合理用药发展。
Abstract: Objective: To provide rational references to the treatment for diabetes, survey the usage of metformin of application under different levels of kidney function among elderly Type 2 Diabetes (T2DM) patients in a general hospital. Methods: Determine the usage of metformin among patients in combination with related guides by retrieving the information of hospitalized elderly patients with T2DM from April, 2012 to June, 2019, extracting one patients’ age, sex, the inpatient department and application of Serum creatinine (Scr), Hemoglobin A1c (HbA1c) and metformin and calculating the average of glomerular filtration rate (EGFR) with the help of the hospital information system (HIS). Results: 1) Among the 16,550 elderly T2DM patients with complete data collection, 1,117 has unreasonable usage of metformin, accounting for the rate of 9.59%. Among them, 347 (2.10%) do not stop taking the metformin in time, and 770 (4.65%) do not adjust the dose in time. 2) Among the 1,117 patients with unreasonable usage of metformin, 384 are males (34.38%) and 733 are females (65.62%), and the average age was (75.92 ± 6.62) years old. Among the samples, 198 cases have Scr within the normal range but eGFR is less than 45 ml/(min∙1.73 m2), accounting for 17.73%. And 762 cases (68.22%) have Scr within the normal range but eGFR is 45 - 60 ml/(min∙1.73 m2). 3) Among the departments on unreasonable usage of medicine, the top one is cardiovascular department, the rate accounting for 26.95%, followed by endocrinology, general medicine, neurology, health care, emergency and severe diseases, and nephrectomy, with a cumulative composition ratio of 91.79%. Conclusion: There is unreasonable usage of metformin in elderly diabetics in general hospitals. The renal function should not be just judged by blood creatinine. Various measures should be taken to promote the development of reasonable drug use.
文章引用:代泳宇, 陈瞳, 张利方, 张雪娟, 张杰涛. 二甲双胍在老年糖尿病患者中应用的现状调查[J]. 临床医学进展, 2020, 10(6): 1017-1023. https://doi.org/10.12677/ACM.2020.106154

参考文献

[1] 母义明, 纪立农, 李春霖, 等. 二甲双胍临床应用专家共识(2018年版) [J]. 中国糖尿病杂志, 2019, 27(3): 161-173.
[2] Holman, R.R., Paul, S.K., Bethel, M.A., et al. (2008) 10-Year Follow-Up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 359, 1577-1589. [Google Scholar] [CrossRef
[3] 陆付耳. 肠道及肠道菌群:糖尿病重要治疗靶点[C]//中国中西医结合学会内分泌专业委员会. 第十二次全国中西医结合内分泌代谢病学术大会暨糖尿病、甲状腺疾病高峰论坛论文资料汇编. 中国中西医结合学会内分泌专业委员会: 中国中西医结合学会, 2019: 147-153, 146.
[4] 钟洪雨, 王炼, 韩晓雨, 等. 二甲双胍治疗改善新生期BTBR小鼠海马神经发生缺陷[J]. 第三军医大学学报, 2020, 42(1): 1-8.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版) [J]. 中国实用内科杂志, 2018, 38(4): 34-86.
[6] Kuo, C.C., Yah, H.C., Chen, B., et al. (2015) Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults with CKD. Medicine, 94, e2175. [Google Scholar] [CrossRef
[7] Antonelli, I.R. (2006) Estimating Renal Function in Older People: A Comparison of Three Formulas. Age & Ageing, (2):2.
[8] 中国医师协会内分泌代谢科医师分会. 2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版) [J]. 中华内分泌代谢杂志, 2019, 35(6): 447-454.
[9] Anoymous. (2020) Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, 77-88. [Google Scholar] [CrossRef
[10] Kristoffer, F., Falk, H., Trine, N., et al. (2015) Disentangling Type 2 Diabetes and Metformin Treatment Signatures in the Human Gut Microbiota. Nature, 528, 262-266. [Google Scholar] [CrossRef] [PubMed]
[11] Irene, R.T., Josep, F.N., Manel, M.C., et al. (2016) Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications? Journal of Diabetes Research, 2016, Article ID: 7502489. [Google Scholar] [CrossRef] [PubMed]
[12] Vinagre, I., Mata-Cases, M., Hermosilla, E., et al. (2012) Control of Glycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Primary Care in Catalonia (Spain). Diabetes Care, 35, 774-779. [Google Scholar] [CrossRef] [PubMed]
[13] 王利杰, 李继泉, 亢卫华, 等. 我院慢性肾功能不全患者合理用药情况调查及典型案例分析[J]. 中南药学, 2019, 17(1): 126-130.
[14] Emslie-Smith, A.M., Boyle, D.I.R., Evans, J.M.M., et al. (2001) Contraindications to Metformin Therapy in Patients with Type 2 Diabetes—A Population-Based Study of Adherence to Prescribing Guidelines. Diabetic Medicine, 18, 483-488. [Google Scholar] [CrossRef] [PubMed]
[15] Cheryl, H., Robb, M., Betsy, B., et al. (2002) Frequency of Inappropriate Metformin Prescriptions. JAMA, 287, 2504-2505.
[16] Calabrese, A.T., Coley, K.C., Dapos, S.V., et al. (2002) Evaluation of Prescribing Practices: Risk of Lactic Acidosis with Metformin Therapy. Archives of Internal Medicine, 162, 434-437. [Google Scholar] [CrossRef] [PubMed]